New York City Mayor Bill de Blasio joined Reverend Al Sharpton and others on Thursday in painting the words "Black Lives Matter" on Fifth Avenue - and right outside of Trump Tower. Lisa Bernhard has more.
Shikha Malhotra, actor and a degree holder in nursing from Delhi's Safdarjung Hospital is working as patient counsellor at Mumbai's BMC Hospital. "Being a new face it is always difficult. When country started facing COVID crisis, I thought I should fight and help. I joined COVID ward. I have completed 105 days on July 09," said Shikha Malhotra.
On July 11, Prime Minister Narendra Modi reviewed COVID-19 situation in the country in a meeting attended by Union Home Minister Amit Shah, Union Health Minister Dr Harsh Vardhan, Member of NITI Aayog, Cabinet Secretary and other senior officials of the central government. PM directed that awareness about COVID should be disseminated widely.
Equity benchmark indices suffered slight cuts during early hours on Friday following a decline in global peers amid surging coronavirus cases. At 10:15 am, the BSE SandP Sensex was down by 36 points or 0.1 per cent at 36,702 while the Nifty 50 edged lower by 8 points or 0.07 per cent at 10,806. Nifty pharma was up by 1.5 per cent and auto by 0.8 per cent. All sectoral indices at the National Stock Exchange were in the red. Among stocks, private lenders IndusInd Bank and Axis Bank slipped by 1.7 and 1.1 per cent respectively while home loan lender HDFC was down by 1.4 per cent. Bharti Infratel dipped by 2.6 per cent, Adani Ports by 2.2 per cent, Tech Mahindra by 1.8 per cent, JSW Steel by 1.4 per cent and Hindalco by 1.2 per cent. Tata Consultancy Services was down by 0.5 per cent to Rs 2,193.05 per share after reporting nearly 14 per cent fall in its net profit at Rs 7,008 crore in the first quarter of the current financial year (Q1 FY21). However, Sun Pharma gained by 2.9 per cent to Rs 496 per share, Dr Reddy's by 1.2 per cent and Cipla by 1.1 per cent. Hero MotoCorp and Tata Motors traded with a positive bias while index heavyweight Reliance Industries was up by 1.1 per cent at Rs 1,844.70 per share. Meanwhile, Asian shares fell as record-breaking new coronavirus cases in several US states raised concerns that new lockdowns could derail an economic recovery. MSCI's broadest index of Asia Pacific shares outside Japan fell by 0.76 per cent while Japanese stocks declined by 0.4 per cent. Shares in China fell by 0.72 per cent, the first decline in more than a week, as investors booked profits on a surge in equities to a five-year high.
Equity benchmark indices were flat during early hours on Thursday as border tensions between India and China continued to simmer while COVID-19 infections surged.At 10:15 am, the BSE SandP Sensex was up by 68 points or 0.2 per cent at 33,576 while the Nifty 50 edged higher by 18 points or 0.19 per cent at 9,900. Sectoral indices at the National Stock Exchange were mixed amid lacklustre trading. Among stocks, private banks slipped with ICICI Bankdown by 1.1 per cent to Rs 338.10 per share. Kotak Mahindra Bank dipped by 0.9 per cent, Axis Bank by 0.8 per cent and IndusInd Bank by 0.6 per cent. The others which lost were ONGC, Adani Ports, NTPC, Larsen and Toubro and Bajaj Auto. However, those which gained marginally were UPL, Bajaj Finserv, ITC, Vedanta, Britannia and Dr Reddy's. Meanwhile, Asian stocks fell as spiking coronavirus cases in several US states and China pushed back hopes of a quick global economic recovery from the pandemic. MSCI's broadest index of Asia Pacific shares outside Japan lost by 1 per cent. Japan's Nikkei was down by 1.3 p
Equity benchmark indices were subdued during early hours on Wednesday amid escalating border tensions between India and China and surge in COVID-19 cases. At 10:15 am, the BSE SandP Sensex was up by 83 points or 0.25 per cent at 33,689 while the Nifty 50 edged higher by 22 points or 0.22 per cent at 9,936. Sectoral indices at the National Stock Exchange were mixed with Nifty PSU bank down by 0.9 per cent but realty up by 1 per cent. Among stocks, the gainers included Maruti Suzuki, Tech Mahindra, Wipro, Britannia, Tata Steel and Axis Bank. However, Bharti Infratel, Power Grid Corporation, Mahindra and Mahindra, Hero MotoCorp and State Bank of India were in the negative zone. Meanwhile, Asian share markets took a breather as a resurgence of coronavirus cases challenged market confidence in a rapid economic recovery. Japan's Nikkei eased by 0.7 per cent after jumping almost 5 per cent a day earlier for its biggest daily gain in three months. MSCI's broadest index of Asia Pacific shares outside Japan went flat, having climbed 2.8 per cent the previous day with most markets across the region little changed.
Shares jumped on Tuesday as sentiment was lifted by the launch of the U.S. Federal Reserve's corporate bond buying program and concerns about a second wave of global coronavirus infections eased. Ciara Lee reports
U.S. stocks rose Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States. Fred Katayama reports.
Gilead Sciences said Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients. Fred Katayama reports.
The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.
Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.
U.S. stocks rose on Friday and posted gains for the week, helped by a surge in Boeing shares, President Donald Trump's plan to reopen the coronavirus-battered economy and hopes of a potential drug by..